Drug Safety And Pharmacovigilance Software Market Report

RA01373

Drug Safety and Pharmacovigilance Software Market, by End User (Pharma and Biotech Companies, Contract Research Organizations (CROs), Business Process Outsourcing (BPO) Firms, Other Pharmacovigilance Service Providers), Delivery Mode (On-premise Delivery Mode, On-demand/Cloud based (SaaS) Delivery Mode), Functionality (Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software): Global Opportunity Analysis and Industry Forecast, 2020-2027

RA01373

Pages: 150

Jan 2023

The global drug safety and pharmacovigilance software market is estimated to surpass $253.1 million by 2027, exhibiting a CAGR of 6.4% from 2020 to 2027.

The report aims to offer a clear picture of the current scenario and future growth of the global drug safety and pharmacovigilance software market. The report provides scrupulous analysis of global drug safety and pharmacovigilance software market by thoroughly reviewing several factors of the market such as vital segments, regional market condition, market dynamics, investment suitability, and key players operating in the market. Besides, the report delivers sharp insights into present and forthcoming trends & developments in the global market.

The report articulates the key opportunities and factors propelling the global drug safety and pharmacovigilance software market growth. Also, threats and limitations that have the possibility to hamper the market growth are outlined in the report. Further, Porter’s five forces analysis that explains the bargaining power of suppliers and consumers, competitive landscape, and development of substitutes in the market is also sketched in the report.

The report reveals various statistics such as predicted market size and forecast by analyzing the major factors and by assessing each segment of the global drug safety and pharmacovigilance software market. Regional market analysis of these segments is also provided in the report. The report segments the global drug safety and pharmacovigilance software market into four main regions including Asia-Pacific, Europe, North America, and LAMEA. Moreover, these regions are sub-divided to offer an exhaustive landscape of the drug safety and pharmacovigilance software market across key countries in respective regions. Furthermore, the report divulges some of the latest advances, trends, and upcoming opportunities in every region.

Furthermore, the report profiles top players active in the global drug safety and pharmacovigilance software market. A comprehensive summary of 10 foremost players operating in the global drug safety and pharmacovigilance software market is delivered in the report to comprehend their position and footmark in the industry. The report highlights various data points such as short summary of the company, company’s financial status and proceeds, chief company executives, key business strategies executed by company, initiatives undertaken & advanced developments by the company to thrust their position and grasp a significant position in the global drug safety and pharmacovigilance software market.

RESEARCH METHODOLOGY

Research Dive has formulated the report by in-house market analysts after deeply scrutinizing the market landscape. The market estimations stated in the report have been derived using proven research methodologies and analytical models & tools. Use of such effective and advanced tools, helps market analysts to scrutinize, filter, and offer highly accurate data and estimations. The report provides an extensive research and analysis backed with numerous factual data, which mainly include industry players’ interviews, renowned and trustworthy sources of statistics, and regional intelligence. The in-depth insights entailed in the report can help investors and market players to understand investment suitability and grab opportunities for developments, partnerships, and investments in the global market.

The research report is formed by collating different statistics and information concerning the drug safety and pharmacovigilance software market. Long hours of deliberations and interviews have been performed with a group of investors and stakeholders, including upstream and downstream members. Primary research is the main part of the research efforts; however, it is reasonably supported by all-encompassing secondary research. Numerous product type literatures, company annual reports, market publications, and other such relevant documents of the leading market players have been studied, for better & broader understanding of market penetration. Furthermore, medical journals, trustworthy industry newsletters, government websites, and trade associations’ publications have also been evaluated for extracting vital industry insights.

KEY MARKET BENEFITS

This report is a compilation of qualitative assessment by industry analysts, detailed information & study, and valid inputs from industry participants & experts across the value chain

An in-depth analysis along with recent trends of the industry are provided in the report to identify & comprehend the prevailing opportunities and the tactical assessment of the global drug safety and pharmacovigilance software market growth

The market size and forecasts are derived by scrutinizing market boomers and restraints, and key developments in the drug safety and pharmacovigilance software market

The report studies the market from 2019 to 2027 and maps the qualitative impact of several industry factors on market segments as well as geographies

The development strategies implemented by the key industry players are conscripted in the report to understand the competitive scenario of the global drug safety and pharmacovigilance software market

The report also offers insights into foremost market players, Porter’s Five Analysis, and top winning business strategies

KEY MARKET SEGMENTS

The global drug safety and pharmacovigilance software market is segmented on the basis of the following:

End User: Pharma and Biotech Companies, Contract Research Organizations (CROs), Business Process Outsourcing (BPO) Firms, Other Pharmacovigilance Service Providers

Delivery Mode: On-premise Delivery Mode, On-demand/Cloud based (SaaS) Delivery Mode

Functionality: Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software

Region: North America, Europe, Asia Pacific, and LAMEA

This segment is further sub-segmented into the following regions:

North America
- U.S.
- Canada
- Mexico

Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe

Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific

LAMEA
- Brazil
- Argentina
- Saudi Arabia
- South Africa
- UAE
- Rest of LAMEA

KEY PLAYERS

The leading players stated in the report are United BioSource Corporation, United BioSource Corporation, Sarjen Systems Pvt. Ltd, Sarjen Systems Pvt. Ltd. The report articulates the business overview including financial and annual performance, newest strategic plans & developments, product range, and SWOT analysis of all the players mentioned in the report.

1. ArisGlobal

2. Ennov Solutions Inc.

3. EXTEDO GmbH

4. Online Business Applications, Inc.

5. Oracle Corporation

6. Sarjen Systems Pvt. Ltd

7. Sparta Systems, Inc.

8. United BioSource Corporation

1. RESEARCH METHODOLOGY
- 1.1. Desk Research
- 1.2. Real time insights and validation
- 1.3. Forecast model
- 1.4. Assumptions and forecast parameters
- 1.5. Market size estimation
  - 1.5.1. Top-down approach
  - 1.5.2. Bottom-up approach
2. REPORT SCOPE
- 2.1. Market definition
- 2.2. Key objectives of the study
- 2.3. Report overview
- 2.4. Market segmentation
- 2.5. Overview of the impact of COVID-19 on Global Drug Safety and Pharmacovigilance Software Market
3. EXECUTIVE SUMMARY
4. MARKET OVERVIEW
- 4.1. Introduction
- 4.2. Growth impact forces
  - 4.2.1. Drivers
  - 4.2.2. Restraints
  - 4.2.3. Opportunities
- 4.3. Market value chain analysis
  - 4.3.1. List of raw material suppliers
  - 4.3.2. List of manufacturers
  - 4.3.3. List of distributors
- 4.4. Innovation & sustainability matrices
  - 4.4.1. Technology matrix
  - 4.4.2. Regulatory matrix
- 4.5. Porter’s five forces analysis
  - 4.5.1. Bargaining power of suppliers
  - 4.5.2. Bargaining power of consumers
  - 4.5.3. Threat of substitutes
  - 4.5.4. Threat of new entrants
  - 4.5.5. Competitive rivalry intensity
- 4.6. PESTLE analysis
  - 4.6.1. Political
  - 4.6.2. Economical
  - 4.6.3. Social
  - 4.6.4. Technological
  - 4.6.5. Environmental
- 4.7. Impact of COVID-19 on Drug Safety and Pharmacovigilance Software Market
  - 4.7.1. Pre-covid market scenario
  - 4.7.2. Post-covid market scenario
5. Drug Safety And Pharmacovigilance Software Market, By Distribution Channel
- 5.1. Overview
- 5.2 Pharma and Biotech Companies
  - 5.2.1 Definition, key trends, growth factors, and opportunities
  - 5.2.2 Market size analysis, by region, 2020-2027
  - 5.2.3 Market share analysis, by country, 2020-2027
- 5.3 Contract Research Organizations (CROs)
  - 5.3.1 Definition, key trends, growth factors, and opportunities
  - 5.3.2 Market size analysis, by region, 2020-2027
  - 5.3.3 Market share analysis, by country, 2020-2027
- 5.4 Business Process Outsourcing (BPO) Firms
  - 5.4.1 Definition, key trends, growth factors, and opportunities
  - 5.4.2 Market size analysis, by region, 2020-2027
  - 5.4.3 Market share analysis, by country, 2020-2027
- 5.5 Other Pharmacovigilance Service Providers
  - 5.5.1 Definition, key trends, growth factors, and opportunities
  - 5.5.2 Market size analysis, by region, 2020-2027
  - 5.5.3 Market share analysis, by country, 2020-2027
- 5.6 Research Dive Exclusive Insights
  - 5.6.1 Market attractiveness
  - 5.6.2 Competition heatmap
6. Drug Safety And Pharmacovigilance Software Market, By Device Type
- 6.1. Overview
- 6.2 On-premise Delivery Mode
  - 6.2.1 Definition, key trends, growth factors, and opportunities
  - 6.2.2 Market size analysis, by region, 2020-2027
  - 6.2.3 Market share analysis, by country, 2020-2027
- 6.3 On-demand/Cloud based (SaaS) Delivery Mode
  - 6.3.1 Definition, key trends, growth factors, and opportunities
  - 6.3.2 Market size analysis, by region, 2020-2027
  - 6.3.3 Market share analysis, by country, 2020-2027
- 6.4 Research Dive Exclusive Insights
  - 6.4.1 Market attractiveness
  - 6.4.2 Competition heatmap
7. Drug Safety And Pharmacovigilance Software Market, By Deployment Mode
- 7.1. Overview
- 7.2 Adverse Event Reporting Software
  - 7.2.1 Definition, key trends, growth factors, and opportunities
  - 7.2.2 Market size analysis, by region, 2020-2027
  - 7.2.3 Market share analysis, by country, 2020-2027
- 7.3 Drug Safety Audits Software
  - 7.3.1 Definition, key trends, growth factors, and opportunities
  - 7.3.2 Market size analysis, by region, 2020-2027
  - 7.3.3 Market share analysis, by country, 2020-2027
- 7.4 Issue Tracking Software
  - 7.4.1 Definition, key trends, growth factors, and opportunities
  - 7.4.2 Market size analysis, by region, 2020-2027
  - 7.4.3 Market share analysis, by country, 2020-2027
- 7.5 Fully Integrated Software
  - 7.5.1 Definition, key trends, growth factors, and opportunities
  - 7.5.2 Market size analysis, by region, 2020-2027
  - 7.5.3 Market share analysis, by country, 2020-2027
- 7.6 Research Dive Exclusive Insights
  - 7.6.1 Market attractiveness
  - 7.6.2 Competition heatmap
8. Drug Safety And Pharmacovigilance Software Market, By Region
- 8.1 North America
  - 8.1.1 U.S
    - 8.1.1.1 Market size analysis, By Distribution Channel, 2020-2027
    - 8.1.1.2 Market size analysis, By Device Type, 2020-2027
    - 8.1.1.3 Market size analysis, By Deployment Mode, 2020-2027
  - 8.1.2 Canada
    - 8.1.2.1 Market size analysis, By Distribution Channel, 2020-2027
    - 8.1.2.2 Market size analysis, By Device Type, 2020-2027
    - 8.1.2.3 Market size analysis, By Deployment Mode, 2020-2027
  - 8.1.3 Mexico
    - 8.1.3.1 Market size analysis, By Distribution Channel, 2020-2027
    - 8.1.3.2 Market size analysis, By Device Type, 2020-2027
    - 8.1.3.3 Market size analysis, By Deployment Mode, 2020-2027
  - 8.1.4 Research Dive Exclusive Insights
    - 8.1.4.1 Market attractiveness
    - 8.1.4.2 Competition heatmap
- 8.2 Europe
  - 8.2.1 Germany
    - 8.2.1.1 Market size analysis, By Distribution Channel, 2020-2027
    - 8.2.1.2 Market size analysis, By Device Type, 2020-2027
    - 8.2.1.3 Market size analysis, By Deployment Mode, 2020-2027
  - 8.2.2 UK
    - 8.2.2.1 Market size analysis, By Distribution Channel, 2020-2027
    - 8.2.2.2 Market size analysis, By Device Type, 2020-2027
    - 8.2.2.3 Market size analysis, By Deployment Mode, 2020-2027
  - 8.2.3 France
    - 8.2.3.1 Market size analysis, By Distribution Channel, 2020-2027
    - 8.2.3.2 Market size analysis, By Device Type, 2020-2027
    - 8.2.3.3 Market size analysis, By Deployment Mode, 2020-2027
  - 8.2.4 Spain
    - 8.2.4.1 Market size analysis, By Distribution Channel, 2020-2027
    - 8.2.4.2 Market size analysis, By Device Type, 2020-2027
    - 8.2.4.3 Market size analysis, By Deployment Mode, 2020-2027
  - 8.2.5 Italy
    - 8.2.5.1 Market size analysis, By Distribution Channel, 2020-2027
    - 8.2.5.2 Market size analysis, By Device Type, 2020-2027
    - 8.2.5.3 Market size analysis, By Deployment Mode, 2020-2027
  - 8.2.6 Rest of Europe
    - 8.2.6.1 Market size analysis, By Distribution Channel, 2020-2027
    - 8.2.6.2 Market size analysis, By Device Type, 2020-2027
    - 8.2.6.3 Market size analysis, By Deployment Mode, 2020-2027
  - 8.2.7 Research Dive Exclusive Insights
    - 8.2.7.1 Market attractiveness
    - 8.2.7.2 Competition heatmap
- 8.3 Asia-Pacific
  - 8.3.1 China
    - 8.3.1.1 Market size analysis, By Distribution Channel, 2020-2027
    - 8.3.1.2 Market size analysis, By Device Type, 2020-2027
    - 8.3.1.3 Market size analysis, By Deployment Mode, 2020-2027
  - 8.3.2 Japan
    - 8.3.2.1 Market size analysis, By Distribution Channel, 2020-2027
    - 8.3.2.2 Market size analysis, By Device Type, 2020-2027
    - 8.3.2.3 Market size analysis, By Deployment Mode, 2020-2027
  - 8.3.3 India
    - 8.3.3.1 Market size analysis, By Distribution Channel, 2020-2027
    - 8.3.3.2 Market size analysis, By Device Type, 2020-2027
    - 8.3.3.3 Market size analysis, By Deployment Mode, 2020-2027
  - 8.3.4 Australia
    - 8.3.4.1 Market size analysis, By Distribution Channel, 2020-2027
    - 8.3.4.2 Market size analysis, By Device Type, 2020-2027
    - 8.3.4.3 Market size analysis, By Deployment Mode, 2020-2027
  - 8.3.5 South Korea
    - 8.3.5.1 Market size analysis, By Distribution Channel, 2020-2027
    - 8.3.5.2 Market size analysis, By Device Type, 2020-2027
    - 8.3.5.3 Market size analysis, By Deployment Mode, 2020-2027
  - 8.3.6 Rest of Asia-Pacific
    - 8.3.6.1 Market size analysis, By Distribution Channel, 2020-2027
    - 8.3.6.2 Market size analysis, By Device Type, 2020-2027
    - 8.3.6.3 Market size analysis, By Deployment Mode, 2020-2027
  - 8.3.7 Research Dive Exclusive Insights
    - 8.3.7.1 Market attractiveness
    - 8.3.7.2 Competition heatmap
- 8.4 LAMEA
  - 8.4.1 Brazil
    - 8.4.1.1 Market size analysis, By Distribution Channel, 2020-2027
    - 8.4.1.2 Market size analysis, By Device Type, 2020-2027
    - 8.4.1.3 Market size analysis, By Deployment Mode, 2020-2027
  - 8.4.2 Saudi Arabia
    - 8.4.2.1 Market size analysis, By Distribution Channel, 2020-2027
    - 8.4.2.2 Market size analysis, By Device Type, 2020-2027
    - 8.4.2.3 Market size analysis, By Deployment Mode, 2020-2027
  - 8.4.3 UAE
    - 8.4.3.1 Market size analysis, By Distribution Channel, 2020-2027
    - 8.4.3.2 Market size analysis, By Device Type, 2020-2027
    - 8.4.3.3 Market size analysis, By Deployment Mode, 2020-2027
  - 8.4.4 South Africa
    - 8.4.4.1 Market size analysis, By Distribution Channel, 2020-2027
    - 8.4.4.2 Market size analysis, By Device Type, 2020-2027
    - 8.4.4.3 Market size analysis, By Deployment Mode, 2020-2027
  - 8.4.5 Rest of LAMEA
    - 8.4.5.1 Market size analysis, By Distribution Channel, 2020-2027
    - 8.4.5.2 Market size analysis, By Device Type, 2020-2027
    - 8.4.5.3 Market size analysis, By Deployment Mode, 2020-2027
  - 8.4.6 Research Dive Exclusive Insights
    - 8.4.6.1 Market attractiveness
    - 8.4.6.2 Competition heatmap
9. Competitive Landscape
- 9.1 Top winning strategies, 2020-2027
  - 9.1.1 By strategy
  - 9.1.2 By year
- 9.2 Strategic overview
- 9.3 Market share analysis, 2020-2027
10. Company Profiles
- 10.1 ArisGlobal
  - 10.1.1 Overview
  - 10.1.2 Business segments
  - 10.1.3 Product portfolio
  - 10.1.4 Financial performance
  - 10.1.5 Recent developments
  - 10.1.6 SWOT analysis
- 10.2 Ennov Solutions Inc.
  - 10.2.1 Overview
  - 10.2.2 Business segments
  - 10.2.3 Product portfolio
  - 10.2.4 Financial performance
  - 10.2.5 Recent developments
  - 10.2.6 SWOT analysis
- 10.3 EXTEDO GmbH
  - 10.3.1 Overview
  - 10.3.2 Business segments
  - 10.3.3 Product portfolio
  - 10.3.4 Financial performance
  - 10.3.5 Recent developments
  - 10.3.6 SWOT analysis
- 10.4 Online Business Applications, Inc.
  - 10.4.1 Overview
  - 10.4.2 Business segments
  - 10.4.3 Product portfolio
  - 10.4.4 Financial performance
  - 10.4.5 Recent developments
  - 10.4.6 SWOT analysis
- 10.5 Oracle Corporation
  - 10.5.1 Overview
  - 10.5.2 Business segments
  - 10.5.3 Product portfolio
  - 10.5.4 Financial performance
  - 10.5.5 Recent developments
  - 10.5.6 SWOT analysis
- 10.6 Sarjen Systems Pvt. Ltd
  - 10.6.1 Overview
  - 10.6.2 Business segments
  - 10.6.3 Product portfolio
  - 10.6.4 Financial performance
  - 10.6.5 Recent developments
  - 10.6.6 SWOT analysis
- 10.7 Sparta Systems, Inc.
  - 10.7.1 Overview
  - 10.7.2 Business segments
  - 10.7.3 Product portfolio
  - 10.7.4 Financial performance
  - 10.7.5 Recent developments
  - 10.7.6 SWOT analysis
- 10.8 United BioSource Corporation
  - 10.8.1 Overview
  - 10.8.2 Business segments
  - 10.8.3 Product portfolio
  - 10.8.4 Financial performance
  - 10.8.5 Recent developments
  - 10.8.6 SWOT analysis

Purchase Options

Individual License $4290 Corporate License $4920

Personalize this research

Triangulate with your own data
Request your format and definition
Get a deeper dive on a specific application, geography, customer or competitor

10% Off on Customization

Speak To The Analyst
Or Schedule A Call

+ 1-888-961-4454 Toll - Free
support@researchdive.com

Drug Safety And Pharmacovigilance Software Market Report

1. RESEARCH METHODOLOGY

1.1. Desk Research

1.2. Real time insights and validation

1.3. Forecast model

1.4. Assumptions and forecast parameters

1.5. Market size estimation

1.5.1. Top-down approach

1.5.2. Bottom-up approach

2. REPORT SCOPE

2.1. Market definition

2.2. Key objectives of the study

2.3. Report overview

2.4. Market segmentation

2.5. Overview of the impact of COVID-19 on Global Drug Safety and Pharmacovigilance Software Market

3. EXECUTIVE SUMMARY

4. MARKET OVERVIEW

4.1. Introduction

4.2. Growth impact forces

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Opportunities

4.3. Market value chain analysis

4.3.1. List of raw material suppliers

4.3.2. List of manufacturers

4.3.3. List of distributors

4.4. Innovation & sustainability matrices

4.4.1. Technology matrix

4.4.2. Regulatory matrix

4.5. Porter’s five forces analysis

4.5.1. Bargaining power of suppliers

4.5.2. Bargaining power of consumers

4.5.3. Threat of substitutes

4.5.4. Threat of new entrants

4.5.5. Competitive rivalry intensity

4.6. PESTLE analysis

4.6.1. Political

4.6.2. Economical

4.6.3. Social

4.6.4. Technological

4.6.5. Environmental

4.7. Impact of COVID-19 on Drug Safety and Pharmacovigilance Software Market

4.7.1. Pre-covid market scenario

4.7.2. Post-covid market scenario

5. Drug Safety And Pharmacovigilance Software Market, By Distribution Channel

5.1. Overview

5.2 Pharma and Biotech Companies

5.2.1 Definition, key trends, growth factors, and opportunities

5.2.2 Market size analysis, by region, 2020-2027

5.2.3 Market share analysis, by country, 2020-2027

5.3 Contract Research Organizations (CROs)

5.3.1 Definition, key trends, growth factors, and opportunities

5.3.2 Market size analysis, by region, 2020-2027

5.3.3 Market share analysis, by country, 2020-2027

5.4 Business Process Outsourcing (BPO) Firms

5.4.1 Definition, key trends, growth factors, and opportunities

5.4.2 Market size analysis, by region, 2020-2027

5.4.3 Market share analysis, by country, 2020-2027

5.5 Other Pharmacovigilance Service Providers

5.5.1 Definition, key trends, growth factors, and opportunities

5.5.2 Market size analysis, by region, 2020-2027

5.5.3 Market share analysis, by country, 2020-2027

5.6 Research Dive Exclusive Insights

5.6.1 Market attractiveness

5.6.2 Competition heatmap

6. Drug Safety And Pharmacovigilance Software Market, By Device Type

6.1. Overview

6.2 On-premise Delivery Mode

6.2.1 Definition, key trends, growth factors, and opportunities

6.2.2 Market size analysis, by region, 2020-2027

6.2.3 Market share analysis, by country, 2020-2027

6.3 On-demand/Cloud based (SaaS) Delivery Mode

6.3.1 Definition, key trends, growth factors, and opportunities

6.3.2 Market size analysis, by region, 2020-2027

6.3.3 Market share analysis, by country, 2020-2027

6.4 Research Dive Exclusive Insights

6.4.1 Market attractiveness

6.4.2 Competition heatmap

7. Drug Safety And Pharmacovigilance Software Market, By Deployment Mode

7.1. Overview